Your session is about to expire
← Back to Search
AAC Intervention for Intellectual Disability
Study Summary
This trial aims to develop an intervention to improve communication for toddlers with IDD and their families. Qualitative methods and experiments are used to assess its feasibility and effectiveness.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I am the main caregiver for a child aged 2 to 3 years with intellectual and developmental disabilities.Children who have very limited ability to speak and communicate using words or gestures.Criterion: Speech-Language Pathologists who work with at least one child who uses AAC.Children must have normal hearing, which means their hearing test results should be between 0 to 25 decibels in at least one ear.Children who have a very significant delay in their development, as measured by a special test called the Mullen Scales of Early Learning.Children who use specific communication behaviors, as measured by a score higher than 7 on the Communication Complexity Scale.My child can sit with support and play with toys.Children must have normal vision, which means being able to see at least as well as 20/80 with at least one eye.My child has been diagnosed with an intellectual developmental disorder.My child's seizures are not controlled by medication.I am a caregiver and I am over 18 years old.My child is between 2 and 3 years old.I am a Speech-Language Pathologist and I am over 18 years old.Children must be able to understand and use at least 50 words, according to what their caregiver says on the MCDI-WG form.My child is exposed to English at home or in the community.I work with children aged 24-36 months with developmental delays, full or part-time.
- Group 1: Early Augmentative and Alternative Communication (AAC) Intervention
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Are individuals currently being enrolled for participation in this experiment?
"According to records published on clinicaltrials.gov, this research study is presently accepting candidates. The initial post date of the trial was July 1st 2022 and it has been updated as recently as February 22nd 2023."
What is the magnitude of the patient cohort participating in this investigation?
"Affirmative. The clinicaltrials.gov database indicates that this study is still actively recruiting participants, which began on July 1st 2022 and was last updated on February 22nd 2023. 50 patients are currently being sought out at a single medical center."
Share this study with friends
Copy Link
Messenger